Peripheral Vascular Stents Market Expansion Driven by Rising Prevalence of Peripheral Artery Disease 2026–2034
Peripheral vascular stents are medical devices implanted in narrowed or blocked blood vessels outside the heart to help restore and maintain blood flow. These devices are commonly used to treat peripheral artery disease (PAD), which can affect blood circulation in the legs and other parts of the body. Depending on the patient's condition and the affected vessel, treatment may involve drug-eluting stents, bare-metal stents, or other specialized vascular stent technologies.
According to Fortune Business Insights, the peripheral vascular stents market was valued at USD 2.10 billion in 2025 & is projected to grow from USD 2.26 billion in 2026 to USD 4.04 billion by 2034, exhibiting a compound annual growth rate CAGR of 7.52% during the forecast period.
Why Is the Peripheral Vascular Stents Market Growing?
The market is expanding due to the rising burden of peripheral artery disease and other vascular conditions that restrict blood flow. Aging populations, diabetes, smoking, and obesity are among the factors associated with vascular disease risk. As diagnosis and treatment needs increase, hospitals and specialized vascular centers are adopting stent-based procedures to restore circulation in affected arteries.
The growing preference for minimally invasive treatments is another important factor. Endovascular procedures use catheter-based techniques to reach the affected blood vessel, potentially reducing the need for open surgery in suitable patients. These procedures can support shorter recovery periods and lower procedural burden compared with more invasive approaches in selected cases.
Key Market Trends
Growing Adoption of Drug-Eluting Stents: Drug-eluting stents are gaining attention because they release medication intended to reduce excessive tissue growth and the risk of restenosis. Their use reflects the wider focus on improving long-term vessel patency and reducing the need for repeat interventions. According to Fortune Business Insights, this category accounted for approximately 49% of the market by type.
Advancements in Stent Materials and Design: Manufacturers are improving stent flexibility, radial strength, and biocompatibility to address different vessel sizes and anatomical challenges. Nitinol and other specialized materials are used in vascular devices where flexibility and durability are important considerations.
Increasing Use of Minimally Invasive Procedures: Catheter-based interventions are becoming an important treatment option for suitable patients with peripheral artery disease. These procedures can allow clinicians to access affected vessels without the need for extensive surgical incisions, supporting demand for stents and delivery systems designed for endovascular use.
Development of Bioabsorbable Technologies: Bioabsorbable stents are an area of research and product development because they are designed to provide temporary vessel support before gradually degrading. Their potential benefits and limitations depend on the material, device design, and clinical application, and adoption will depend on evidence of safety and effectiveness.
Improved Imaging and Delivery Systems: Advanced vascular imaging and improvements in catheter delivery systems can help physicians navigate complex vessels and position stents accurately. These technologies support procedural planning and device placement, particularly when treating difficult lesions.
Peripheral Vascular Stents Market Dynamics
Driver: Rising Prevalence of Peripheral Artery Disease
The growing prevalence of peripheral artery disease is a major factor supporting market demand. PAD occurs when narrowed arteries reduce blood flow, commonly affecting the lower extremities. Diabetes, smoking, high cholesterol, and aging can increase the risk of developing vascular disease and related complications.
Restraint: High Treatment Costs and Potential Complications
Peripheral vascular interventions can involve significant costs related to devices, imaging equipment, hospital services, and specialized clinical expertise. These expenses may restrict access in healthcare systems with limited budgets or reimbursement coverage.
Opportunity: Expansion of Minimally Invasive Vascular Care
The increasing use of minimally invasive vascular procedures creates opportunities for manufacturers of peripheral vascular stents and related delivery systems. Hospitals and specialized cardiovascular centers are investing in catheter-based treatment capabilities to manage vascular disease and improve procedural efficiency.
Challenge: Managing Restenosis and Complex Vascular Anatomy
Treating peripheral artery disease can be challenging when lesions are long, heavily calcified, or located in vessels that experience frequent movement. These conditions can complicate device placement and affect long-term treatment outcomes.
For Detailed Market Insights
Market Segmentation Analysis
The peripheral vascular stents market is segmented by type, mode of delivery, product, end-use, and region.
By Type: The market includes drug-eluting stents, bare-metal stents, and bioabsorbable stents. Drug-eluting stents accounted for approximately 49% of the market by type. These devices release medication intended to reduce excessive tissue growth within the treated vessel. Bare-metal stents provide mechanical support without a drug coating, while bioabsorbable stents are designed to provide temporary support before degrading. Adoption depends on the clinical indication, device characteristics, and available evidence.
By Mode of Delivery: The market includes delivery approaches used to position and deploy stents within affected blood vessels. Delivery systems are important because they help physicians navigate vascular anatomy and place devices at the intended treatment site. The segment accounted for approximately 38% of the market, according to Fortune Business Insights.
By Product: Product categories include different stent designs and configurations developed for specific vascular conditions and anatomical requirements. These may include self-expanding, balloon-expandable, and covered stent designs. Selection depends on the vessel being treated, lesion characteristics, and clinical judgment.
By End-use: The market serves hospitals, specialty cardiovascular centers, and other healthcare facilities that perform vascular interventions. Hospitals and specialized centers require interventional equipment, imaging systems, and trained clinical teams to diagnose and treat peripheral artery disease. Demand across end-use settings is influenced by the availability of vascular services and the adoption of minimally invasive treatment methods.
Regional Insights
North America: North America dominated the peripheral vascular stents market with a 39% share in 2025. The region benefits from established cardiovascular care infrastructure, access to advanced vascular interventions, and continued adoption of minimally invasive procedures. The United States is a key market, supported by specialized cardiovascular centers and demand for advanced stent technologies. Growing awareness of peripheral artery disease and investments in endovascular treatment capabilities also support regional demand.
Europe: Europe accounted for approximately 29% of the market. Established healthcare systems, cardiovascular disease management programs, and access to specialized vascular services support the adoption of peripheral vascular stents. Countries such as Germany, the United Kingdom, France, and Italy contribute to regional demand through their hospital networks and vascular intervention capabilities.
Asia-Pacific: Asia-Pacific held approximately 24% of the global market. Improvements in healthcare infrastructure, increasing awareness of peripheral artery disease, and expanding access to minimally invasive procedures are supporting market development. Japan is an important market with advanced healthcare infrastructure, while China and India offer opportunities as vascular treatment services continue to develop.
Rest of the World: Markets across Latin America, the Middle East, and Africa are gradually expanding access to vascular diagnostics and interventional care. Growth opportunities are associated with the development of specialized cardiovascular centers and greater availability of minimally invasive treatments. However, affordability, reimbursement, and access to trained specialists may influence adoption.
Competitive Landscape
The peripheral vascular stents market includes medical device companies developing vascular implants, drug-eluting technologies, and catheter-based delivery systems. Competition is shaped by product performance, safety, device flexibility, clinical evidence, regulatory approvals, and access to hospital and specialist distribution networks.
Companies identified in the Fortune Business Insights report include Boston Scientific Corporation, Medtronic, Terumo Corporation, Abbott, Biotronik, Lifetech Scientific, iVascular, Stryker, Cook Medical, MicroPort Scientific Corporation, and Cordis.
Investment Analysis
Investment opportunities are emerging in advanced vascular implants, drug-eluting technologies, minimally invasive delivery systems, and materials designed to improve device performance. Manufacturers are investing in research and development to address restenosis, improve flexibility, and support treatment of complex vascular lesions.
New Product Development
New product development in the peripheral vascular stents market focuses on improving stent flexibility, durability, delivery accuracy, and long-term vessel patency. Manufacturers are refining drug-eluting coatings and stent designs to address restenosis and the demands of different vascular anatomies.
Future Outlook
The peripheral vascular stents market is expected to grow through 2034 as the burden of peripheral artery disease increases and healthcare providers continue adopting minimally invasive vascular interventions. The market is projected to expand from USD 2.26 billion in 2026 to USD 4.04 billion by 2034, at a CAGR of 7.52%.
Request Free Sample PDF
What’s Driving Japan’s Market? Discover the Latest Peripheral Vascular Stents Market Insights
Comments